1

CURRICULUM VITAE Hassan Mohamed Ali (B.Pharm, U. of K. , MSc,& PhD, Univ of London)

Title Professor of Pharmacology Date of Birth February 18th, 1945 Nationality Sudanese Religion Islam Marital Status married, with six children Present Position & Address Dean Faculty of Graduate Studies & Research

National University - Sudan P.O. Box 3783 Khartoum 11111, SUDAN

Consultant & Coordinator of Pharmacy Programmes & Research , University of Medical Sciences & Technology, P.O.Box : 12810,

Khartoum, Sudan, Tel: +249183223385/224762, Fax: +249183224799.

Deputy Director General (DDG) & Scientific Adviser to the DG (AdVSci), International Biographical Centre (IBC), St Thomas' Place, ELY, CB7 4GG, Cambridge, GREAT BRITAIN

Cell: +249919694812, Tel: +249183251031, Fax: +249183251030 Email: jylane1845@gmail.com , hassan1845@nu.edu.sd

Education

March. 1970 B. Pharm. Faculty of Pharmacy, University of Khartoum, Sudan

October. 1973 MSc. (Biopharmacy), Chelsea College, Univ. of London, UK

March. 1977 Ph.D. (Drug Disposition & Metabolism), Chelsea College, Univ. of London

Aug-Sept 1981 Postgraduate Specialization Course in Pharmaceutical Technology, by: UNIDO – WHO – Gov. of Belgium (Ghent, Belgium).

Positions

(a) University Of Khartoum (U of K)

Assistant Prof. of Pharmacology, Faculty of Pharmacy, U of K ………. 1977 – 1983 Associate Prof. of Pharmacology, Faculty of Pharmacy, U of K ……… 1983 – 1988 Professor of Pharmacology, Faculty of Pharmacy, U of K ……………… 1988 – On Head Dept. of Pharmacology, Faculty of Pharmacy, U of K ……………. 1981 – 1988 Secretary Faculty of Pharmacy Research Board, U of K …………………. 1981 – 1988 Chairman Faculty of Pharmacy Research Board, U of K ………………… 1989 – 1993 Dean Faculty of Pharmacy, U of K ………………………………………………… 1989 – 1993 Member of U of K Senate ……………………………………………………………… 1981 – 1993

2

Member of U of K Central Research Committee …………………………….. 1989 – 1993 Member of U of K Executive & Finance Committee ………….……………. 1991 – 1993 Member of U of K Council …………………………………………………………… 1989 – 1993 Chairman U of K Higher Committee for Arabicization …………………… 1991 – 1993

(b) Others

Head Dept. of Pharmacology, Faculty of Pharmacy, Univ. of Sanna'a, Yemen 1994 – 1995 Consultant to the Minister of Health, Republic of Yemen …………………………… 1995 – 1996 Director, Pharmaceutical Research Unit, Royal Scientific Society(RSS), Jordan 1996 – 1999 Consultant/Assessor to the Higher Council for Science & Technology

(HCST-RSS), Jordan ……………………………………………………………………………………. 1996 – 1999 Professor of Pharmacology, Amman Al-Ahlia & Al Zaytoona Univs., Jordan 2000 – 2005 Consultant, Faculty of Pharmacy, International Univ. of Africa, Sudan ………..... 2005 – 2007 Consultant, Univ. of Medical Sciences & Technology, ( Sudan ) ……………………. 2005 – On Coordinator, Pharmacy Program, National College for Medical & Technical

Studies, Sudan …………………………………………………………………………………………... 2005 – 2012

National & International Appointments

(a) National Member, Higher Standing Committee for drug Registration (MOH, Sudan), (1980-1993)

Member, National Permanent Committee for Drug Tenders (MOH, Sudan), (1983-1987)

Medical Research & Clinical Trails Code of Ethics Committee (Member &Reviewer), (1988-

1991)

Member, National Committee for Drug Policy & Essential Drugs Program (1983-1988).

Consultant and Scientific Advisor: Board of Director, Wafra Co., State Medical Corps Economic

Corporation, (Nov. 1985-May 1987).

Member of the Advisory Ed. Board of Sudan Medical Journal, (Feb. 1988-1992)

President, Sudanese Pharmacological Society (1988-1990)

President, National Committee for Drug Policies (1990)

Member, National Committee for Promoting Local Drug Industry (1990)

Member of the Drugs & Therapeutics Committee, National Health Insurance Fund (2011-On).

Consultant and Chairman: Committee for the Evaluation of the Revolving Drug Fund

Performance on Drug Supply Management (RDF, MOH, Khartoum State), (2011-2012).

Consultant: Board of Directors of the RDF (MOH, Khartoum State), (2011-On).

Member of Pharmacy Council (MOH, Khartoum State) & Chairman of the Committee for: The

Private Pharmaceutical Sector Practice (2012-On).

Advisor to: National Medicines & Poisons Board (NM&PB, Federal MOH, Sudan) on: Clinical

Pharmacokinetics & Bioequivalence Studies; Guidelines for the Registration of Biological

Products (2010-On).

Quality Manager, Managing Board, Sudan Medical Monitor (SMM, ISSN: 1858-5000), National

College For Medical & Technical Studies – Sudan (2006-On).

Member of the Consultancy Council for Pharmaceutical Services, Federal Ministry of Health,

Khartoum, Sudan, (January 2009).

Chairman of the Committee for Licensing & Registration of Local & International Drug

Manufacturers, NM&PB, Federal Ministry of Health, Republic of Sudan, (Dec. 2013-On).

Member of the Board of Trustees , Al Bayan College for Science & Technology, Khartoum,

Sudan ( May 2015 – On ).

3

(b) International

Co-Editor: African Journal of Pharmacology (1984-1985).

Assistant General Secretary of the Union of African Societies of Pharmacology (UASPHAR)

(1987-1989).

Consultant to WHO: Working group for the Introduction of the Concept of Essential Drugs in Pharmacy &

Medicine Curricula (Geneva-1984).

Seminar/Workshop: The Importance of Adherence to the Concept of Essential Drugs

(Khartoum, 1985).

Preparation of Information Sheets for Drugs include in National List of Essential

Drugs (Egypt, Alex.1986).

Development and Teaching of a Clinical Pharmacology Curriculum with special

emphasis on the Concept of Essential Drugs and Rational Prescribing

(Yemen,Aden,1991).

Initiate, Implement and supervise the course: “Selected Topics in

Pharmacotherapeutics” , Teaching and Advising on the Establishment of Research in

clinical Pharmacology”, “ Revision and Updating of Pharmacology Curriculum ,

Faculties of Medicine “, (Yemen, Sana’a & Aden, 1992).

Teaching Rational Drug Use in Medical Schools. WHO & Federal MOH, Khartoum,

Sudan (Dec. 2007).

Workshop in Pharmaceutical Human Resources Consultation: Towards Strategic

Development Framework. Federal MOH (Sudan) In Coordination with WHO & FIP

(Aug. 2010).

Consultant to UNICEF: Design of the methodology and implementation of Essential Drugs, Field Work and Reporting

(Southern Yemen-1995).

Consultant to IUPHAR:

Represented IUPHAR in the 1st. Congress of toxicology in Developing Countries (Buenos

Aires, Argentina, Nov.1987).

Coordinator of Drug Dumping Information, Reports and Records- for the African Drug

Utilization Research Group (Executive Board, Jan. 1988-1992).

WHO Drug Utilization Res. Group (87/1992).

African Drug Utilization Res. Group (88/1992).

International Network for Rational Use of Drugs (INRUD, Boston, USA), Exc. Board

(89/1992).

Health Action International (HAI Key Contact in Sudan, 1986), Draft “Code of Conduct for

Donors & Recipients of Drug Donation” (HAI, March 14th 1988).

Deputy Director General (DDG) of the International Biographical Centre (IBC) Cambridge,

England (Feb. 2004).

Scientific Advisor to the IBC Director General, ( AdVSci ), Cambridge, England (Feb.2006).

Consultant to Jordan Center For Pharmaceutical Research ( JCPR ), P.O.Box : 950435, Amman

11195 Jordan, E-mail: www.jcpr.jo.com ( 2014…..On ).

Professional Societies Membership

4

o The British Pharmacological Society (Jan. 1981-1988)

o The British Society for Antimicrobial Chemotherapy (1981-1988)

o The American Society for Pharmacology and Experimental Therapeutics (1983-1988)

o The International Union of Pharmacology (IUPHAR.1983-1988)

o Union of African Societies of Pharmacology (UASPHAR Oct 1983 -1992)

o International federation of Pharmacy (Fip-1981-1992)

o Pharma IQ ( A Division of IQPC ) www.gpcmevent.com ( 2013-------On ).

o E-Drug…..FH1360-SATELLIFE Center for Health Information and Technology

(www.heakthnet.org )….. ( 2014 …….On ).

Academic Activities, Research Grants & Awards

(a) Grants: NIH, Washington Dc. (USA, 1984 – 1990). Central Research Committee, Univ. of Khartoum (Sudan, 1980 - 1992). Michigan State Univ. (USA, 1984 - 1990). Clark Foundation N.Y. (USA, 1984). WHO (Geneva & EMRO, 1984 - 1999). British Council , Amman-Jordan ( 1997 – 1999 ) Merck Co. (USA), Upjohn, Rhone P. (France). War-on-Want (N.Ireland , 1985 - 1986).

Italian Government (May 1986).

RDF, Ministry of Health, Khartoum State ( 2013 – 2014 )

(b) Awards :

Man of the Year-2003- by the American Biographical Institute & its Board of

International Research (North Carolina, USA).

21st Century Award for Achievement, Illuminated Diploma Of Honour in

Pharmacotherapeutics, By: IBC, Cambridge, England (Aug. 2004).

The 2005 INTERNATIONAL PEACE PRIZE by : The Authority of the United Cultural

Convention sitting in the United States of America (March 2005).

RECOGNITION AWARD , ACDIMA BIOCENTER, Amman- Jordan ( Feb. 2015 ).

Experience

1. Teaching

a) Undergraduate: Special topics in pharmacodynamics , drug disposition, metabolism, clinical pharmacology, therapeutics, pharmacokinetics, pharmacoepidemiology, pharmacoeconomics. Faculties of Pharmacy, Medicine , Dentistry, Veterinary Sciences & Nursing (Univ. of Khartoum, Sudan); Faculties of Pharmacy, Medicine & Med. Lab (Univs. of Sana’a & Eden, Yemen); Faculties of Pharmacy (Amman Al Ahlia & Al-Zaytoonah Univs., Jordan); Faculties of Pharmacy, Medicine, & Dentistry (University of Medical Sciences & Technology; National College For Medical & Technical Studies, Sudan); Faculty of Pharmacy (International Univ. of Africa, Sudan).

5

b) Postgraduate: Topics: Clinical pharmacology, therapeutics, drug disposition, metabolism, pharmacokinetics, pharmacoepidemiology, and pharmacoeconomics. M. Pharm., Faculty of Pharmacy (Univ. of Jordan, Jordan, 1998); M.Sc. Pharmacology in clinical pharmacokinetics (University of Medical

Sciences & Technology, Sudan, 2006 – On).

2. Research

A. Publications B. Communications C. Postgraduate Programs Supervision D. Examiner for the Award of Postgraduate Degrees (M.Sc. & PhD) &

Assessor for the Promotion of Academics to the Positions of Assoc. Prof. & Prof.

A. Research Publications

1- Beckett A.H. & Ali HM.1977. Metabolic Oxidation of a tertiary amine to produce an N-glucuronide. In Biological Oxidation of Nitrogen Conference. (J.W Gorrod,ed.) Elsevier/North Holland Biomedical.pp. 10 1-107.

2- Beckett A.H. & Ali H.M.1979. Artifacts produced by using dichloromethane in extraction and storage of some antihistaminic drugs. J.Chrom.77:225-262.

3- Ali H.M. and Beckett A.H.1980. The effect of a new metabolite after incubation of N-benzylaniline with rabbit liver microsomes. J.Chrom. Biomed. 202(2):287-293.

4- Ali H.M. and Farouk A.M. 1980. The effect of a Sudanese diet on the bioavailability of Ampicillin. Int.J.Pharma.6:30 1-306.

5- Ali H.M. and Beckett A.H. 1981. Identification of two new metabolic products after liver microsomal incubation of Antazoline. J.Chro. Biomed. 210(2): 350-355.

6- Ali H.M. 1981. The effect of Sudanese food and chloroquine on the bioavailability of Ampicillin from Bacampicillin tablets. Int.J.Pharm.9 (3):185-191.

7- Ali H.M. 1981. Comparative bioavailability of eight brands of Ampicillin. Int.J.Pharm. 7:301-306. 8- Ali H.M. 1981. Bioequivalence studies on two brands of Bacampicillin. Int.J.Pharm. 9:91-95. 9- Ali H.M. and Beckett A.H. 1981. A rapid method for the determination of chloropheniramine in

urine. J.Chrom.Biomed. 233(1):208-212. 10- Ali H.M. Farouk A.M., Khalil S.A., & El Nakeeb M.A. 1981. Correlation between

microbiologicalvand chemical assay of Ampicillin in Bioequivalence studies in man. Int.J.Pharm. 9(3): 233-237.

11- Ali H.M. A/Alla W. & Hussein F.T. 1981. Comparative bioavailability of three brands of Amoxicillin marketed in Egypt. Egypt.J.Pharm.Sci. (4):283-287.

12- Ali H.M. 1982. Prediction of drug-food interactions. Pharm.Int 3(27):102. 13- Ali H.M., Homeida M.M.A. and Hassan I.E.Z.1983. Effect of ethnic origin on Ampicillin body

levels. Br.J. of Clin. Pharmac. 16:576-577. 14- Ali H.M. El Tahir D.E.D.H.,Osman O.H. and Shakir L. 5.1983. Hyperpyrexic interactions

betweentranylcypromine, opioid compounds & dexepin in rabbits. Br.J.of Pharmac. (Supplement) 80,564p.

15- Ali H.M. El-Tahir K.E.D.H., Osman O.H.& Shakir L.S. 1983. Toxic interaction between tranlcypromine and dopaminergic drugs in rabbits.Br.J of Pharmac.(supplement) 80, 577.

16- Ali H.M. Bennett J.L. & Sulaiman S.M.1984.Simple & rapid method for the determination of Oltipraz, a new antischistosomal agent in blood. J.Chrom. Biomed. (305): 465-469.

17- Ali H.M. Bennet J.L., Sulaiman S.M. & Homeida M.M.A. 1984.Effect of cysteine on the blood levels of Oltipraz in healthy Cercopithecus aethiops green monkeys. J.Chemother. 30:255-261.

18- Ali H.M. Homeida M.M.A., Sulaiman S.M. and Bennett J.L. 1984.Diet-controlled Oltipraz blood level in healthy male subjects. J.Anticrob. Chemother. 13:465-470.

19- Ali H.M.1985. Pilot trail on the introduction of the concept of essential drugs in university curricula-Sudan example, WHO (Geneva,Dec.10-14,1984). Report DAP/85-5:23-32.

6

20- Ali H.M. 1985. Reduce Ampicillin bioavailability following oral co-administration with Chloroquine.J.Antimicrob. Chemother. 15:781-184.

21- Ali H.M., Homeida M.M.A and Ibrahim E.Z.H.1985. Investigations on the influence of liver diseases on Ampicillin body levels in man .J.Antimicrob. Chemother. 15;737-442.

22- Chatterjee R., Ali H.M., Daood M.F. & Chatterjee A.1985. Chloroquine and premature evacuation of uterine concepts in rats. Contraception 31 (2): 172-175.

23- El Wakel E.S, Homeida M.M.A. Ali.H.M. Geary T.C. & Jensen J.B. 1985. Clindamycin for the treatment of Falciparum Malaria in Sudan. Am J.Trop. Med.Hyg. 34(6): 1065-1068.

24- El Khalifa M.Y., Homeida M.M.A., and Ali H.M. 1985. Treatment &Management of onchocerciasis in Sudan. Sudan Med.J. 21:73-81.

25- Homeida M.M.A., Ali.H.M. Danesshmend T.K. 7 Kaye C.M. 1986. Metronidazole Kinetics in children with giardiasis following oral benzoylmetronidazole suspension. Br.J.Clin.Pharmac.21(1):114-115.

26- Homieda M.M.A, Ali H.M. Suliman S.M. & Bennett J.L. 1986. Oltipraz administration with food increase its antischistosomal activity. Trans.Roy.Soc.Trop.Med.Hyg.80: 908-910.

27- Homeida M.M.A. Ali H.M. Suliman S.M. & Benett J.L. 1986. Measurement of peak blood concentrations and correlation with the drugs (antischistosomal action). Ann.Trop.Med.Parasit. 80 92): 369-371.

28- Ali H.M., Homeida M.M.A. Rasheed A.R.E. and Beckele I. 1986. Sudan national drug policy proves it worth. Int. Health forum (WHO). Vol.7(3): 256-260.

29- Ali H.M. Homeida, Tawfique K.Daneshmend, Hassan, M.Ali & Clive M.Kaye. 1986. Metronidazole Benzoyl ester in the treatment of children infected with giardiasis: Disposition & efficacy. J.Antimicrob.Chemether. 18(2): pp.213-219.

30- Ali H.M. 1987. Problems in assessing rationality of drug utilization in less developed countries. Acta MedicalScandinavian Dec. 1987 issue.

31- Homieda M.M.A. Ali H.M. Arbab B.M.O. and Harron D.W.G. 1987. Propanolol bioavailability in patients with hepatosplenic schistosomiasis. Br.J.ofClin. Pharmac. 24:393-396.

32- Khalil E.A.G., Homeida M.M.A. Ali H.M., Suliman S.M. & Bennett J.L. 1985. Efficacy & Tolerance of two brands of Praziquantel: Biltricide & Distocide. Sud.Med.J.985; vol.23: 3-12 p. 21-15.

33- El Tahir K.E.D.H., Ali H.M., Osman O.H. Shakir L.S. 1985. Dopamine involvement in tranylcypromine/opioid compounds and doxepin-induced hyperpyrexia in rabbits. Sudan Med.J. 1985; vol.23: 21-25,p43-50.

34- Drugs utilization studies: their transferability between industrialized and developing countries-D.Lee,K. Balasubramaniam and Hassan M. Ali (1993); In Drug Studies-Methods and Uses. E.d. By M.N.G.Dukes, Who Regional Publications, European Series No. 45;ICP/DSE127; Text editing by Pamela M. Charlton; pp.193-218.

35- Ali H.M., Homeida M.M.A. Ford J., Truman C.A., Roberts C.J.C.& Badwan A.A. 1988. Paracetamol bioavailability & pharmacokinetics from an alcohol-free solution, suspension & elixir. J.Int. Pharm. 42:p. 155-159.

36- Ali H.M.Homieda M.M.A., Sulaiman S.M. 7 Bennett j.l. 1986. Effect of food on Oltipraz Pharmacokinetics & antischistosomal efficacy. South East Asian J.Trop.Med. Pub. Hlth.

37- Harron D.W.G., Ali H.M. & Homeida M.M.A. 1986. Proprnolol bioavailability in patients with hepatosplenic bilharziasis. Act Pharmacological toxicological (suppl Vol. ) II, p.221.

38- Ali H.M., Homeida M.M.A. & Abdeen M.A.R. 1988. Have donations to Sudan been used as Drug Dumping’'? Lancet, March 5th . 1988.

39- Homieda M.M.A., A-/Ibagi I., Galib H.W.,Sheikh E.H.E., Ali H.M., Ismaeil A.,Yousif M.A, Sulaiman S.M, Bennett J.L& Williams J.F Prolongation of prothrombin time with Ivermectin therapy ; LANCET, April 30 .1988. Published, Lancet June, 1988.

40- Ahmed M.E.K., Arbab B.M.O., Homeida M.M.A.& Ali H.M., 1988. Cimetidine in the treatment of Sudanese patients with duodenal ulcer . Sudan Med. J., 24(1-4): pp.38-43

41- Homeida M.M.A., Ismail A.A., Tom I.E., Mahmoud B.M. & Ali H.M. 1988. Resistant malaria and the Sudan floods. The Lancet, Oct.15 .1988, pp.912.

42- Ahmed M.E.K., Arbab B.M., Homeida M.M.A., Ali H.M & Subahi M. Comparative study of tow ranitidine brands in the treatment of duodenal ulcer in Sudanese patients. Sudan Med.J. 25: (1-

7

4) 1988. 43- Suliman S.M., Ali H.M., Homeida M.M.A. & Bennett J.L. 1988. Efficacy of a New Hoffman-Laroche

compound in green monkeys (Cercopithecus aethiops). Trop. Med. Parasite. 40 1989; 335,336. 44- Ali H.M. & Homeida M.M.A. 1989. Provision & maintenance of adequate pharmaceutical services

at prices the vast majority of the Sudanese population could afford. Facts & Figures Int. Pharmacy J. Vol. 3 (6):pp. 224-226.

45- Omer M., Gasim T.A., Homeida M.M.A., Ali H.M., Wakeel E.S.E., Geary T.G., Westerman R.L. and Jensen J.B. 1989. A comparison of chloroquine & clindamycin for the treatment of uncomplicated plasmodium falciparum malaria in Sudan. Sudan Med. J. 27 (1-4) 1988.

46- Homeida M.M.A., Eltom I.A., Suliman S.M., Ali H. M. & Bennett J.L. 1989. Tolerance of tow brands of praziquantel. Lancet Vol.2,. 12, 1989, pp. 8649.

47- Ali H.M. & Homeida M.M.A. 1989. Preliminary disease epidemiology studies in rural communities settlements at the peripheries of Khartoum, June Sept.1988/ A book published by Khartoum University Press, P.O Box 321 , Khartoum, Sudan.

48- Ali H.M.& Mahmoud B.M> 1990. Bioequivalence studies on locally manufactured (Ampicillin)

and imported (Penbritin & Pentrexyl) Ampicillin brands marketed in Sudan Med. J. 28 (1-2): 1990.

49- Ali H.M. & Mahmoud B.M. 1990. Bioequivalence of tow cephalexin brands. Sudan Med. J. 1990. 50- Mandor M.E.M., Turabi H.E., Homeida M.M.A., Ali H.M. .Bennett J.L., Leahey W.J. & Harron D.W.G

1990. Pharmacokinetics of Praziquantel in in healthy volunteers and patients with schistosomiasis. Transaction of the Royal Society of Tropical Medicine and Hygiene (1990) 84, 389-393.

51- Ali H.M. & Homeida M.M.A. 1988. The concept of Essential Drugs for the Faculties of Pharmacy and Medicine, University of Khartoum a book commissioned by WHO.

52- Richard O. Laing Dennis Ross Degnan, Jonathan Quick, Hassan M.Ali, David O.Adejei, Lateef Salako and Budiono Santos (1991). Improved Pharmaceutical Use. The International Network for Rational Use of Drugs (INRUD). Soc. Sci. and Med. (1992) Dec;35(11);1329-41.

53- Ali H.M., A.A./Karim, F.F.I., EI-Tayeb I.B. & Banaga N.H. (1992). How Rational is Prescribing in Sudanese Teaching Hospitals? Sudan Medical J., Khartoum, Sudan; (1993).

54- A.A./Karim, E.F.I; Khidir H., Ali H.M. Zaidan, Z.A; Barka, O.Z, Homeida, M.M.A. & EI-Tayab, I.B. (1992). Pharmaceutical Services in three Health Areas in North Kordofan, Sudan Medical J., Khartoum, Sudan. (1993).

55- Ali H.M., Homeida M.M.A., EI-Tayab, I.B., & A./Karim, E.F.I. (1993). Generic vs. Brand Prescribing in Six Main Hospital in Sudan Capital Region. Sudan Med.J. 1993.

56- Mahmoud B.M.; Ali H.M. Homeida M.M.A. Homeida & Bennett, J.L. (1993). Bioequivalence of chloroquine brands marketed in Sudan; J. Int.Pharm. 1993.

57- Mahmoud B.M.; Ali H.M. Homeida M.M.A & Bennett, J.L. (1993). Substantial reduction in chloroquine bioavailability following coadministration with common Sudanese beverages; J. Antimicrob. Chemother., 33, 1993.

58- Ali H.M. and A./Karim, E.F.I. (1993). Suicidal by P-Phenyl-enediamine in Hena Dye. Journal of the Eastren Mediterranean Region, WHO Vol. 6, 2, 1992.

59- Omer A. Attif, Abdul-Azem A. Ali & Hassan Mohamed Ali (1997). Effect of Khat Chewing on the bioavailability of Ampicillin & Amoxicillin. J.Antimicrob Chemotherapy (1997) 39. 523-525.

60- R.M. Azzam, L.J. Notarianni & H.M Ali (May 1998). Rapid and Simple Chromatographic Method for the determination of diazepam and its major metabolites in human plasma & urine. J. Chrom. Biomed. 708 (1998) 304-309.

61- Malik M.O, Ali M.H., Homeida M.M.A, Ghalib H.W., Suleiman S.M., El-Sheikh E.A., Zayed O, & Mahmoud B.M. Breach of trust in Sudan. Nature. 1991 Dec 5; 354 (6352):346.

62- Rayan K. Mahmoud. & Hassan M.Ali. (2013).Analysis of price discrepancy and its impact on rational use of drugs. Sudan Medical Monitor , vol. 8(4), pp: 189 – 193.

63- Sabah E. A. Eltegani, Hassan Mohamed Ali & Almoeiz Y. Hammad ( Oct. 2013 ). The Hazards of Hidden Heavy metals in Face Make-Ups. Br. J. Pharmacol. Toxicol., 4(5):188-193, Oct. 2013.

64- Rayan K. Mahmoud, Salah I. Kheder & Hassan M. Ali (2014) Prescribing rationality in Khartoum State, Sudan: An Update. Sudan Medical Monitor ; Vol: 9; Issue: 2; pages: 61 – 66.

65- Salah I. Kheder & Hassan M. Ali ( 2014 ).Evaluating medicines prices , availability,

8

affordability and price components in Sudan . Sudan Medical Monitor ; vol: 9; issue: 1; pages: 19 – 30.

B. Communications:

i) National Conferences

1) Ali H.M. Comparative bioavailability studies in man of various brands of Ampicillin 7th. Conferences of the Sudan Association of Physicians. Faculty of Medicine, University of Khartoum. Jan. 1980.

2) Ali H.M. Oltipraz (a new schistosomal drug); Metabolisim disposition, bioavailability and pharmacokinetics (review). Tropical Diseases Meeting of the National Institutes of Health (NIH-USA), Hilton, Khartoum, Sudan Association of Physicians 9th. Conference Khartoum, Sudan Feb. 1982.

3) Ali H.M. Homeida M.M.A., Sulaiman S.M. and Bennett J.L. Oltipraz in the treatment of S.Mansoni and S.Haematobium, Sudan Association of Physicians 9th. Conference Khartoum, Sudan, Feb.1984.

4) Ali H.M. 1985. The importance of adherence to the concept of essential drugs in Sudan. WHO, Workshop/Seminar; Khartoum, Sudan Nov. 1985 (Invited Temporary Consultant).

5) Baraka O.Z., Homeida M.M.A., Tigani A.E., Mukhtar B.I. & Ali H.M. 1986. Pilot study for the prevalence of HIV carrier in Sudan. Sudan Association of Physicians, 10th. Con. Khartoum, Sudan; Feb. 24-27, 1986.

6) Ali H.M., Homeida M.M.A., Ford J., Truman C.A., Roberts C.J.C. & Badwan A.1986. Paracetamol bioavailability & pharmacokinetics from conventional liquid dosage forms and a newly introduced alcohol-free solution. Sudan Association of Physicians, 10th. Con. Feb. 24-27, 1986.

7) Hassan M. Ali., Homieda M.M.A. & Mohamed A.E.R. Abdeen. Have donations to Sudan been as Drug Dumping 13th Sudanese Physicians Conf. Feb 1992 Khartoum.

8) Babiker M.M., Ali H.M., Homieda M.M.A. and Bennett J.L. Bioequivalence of different brands of chloroquine tablets marketed in Sudan 13th Sudanese Physicians Conf. Feb 1992 Khartoum.

9) Babiker M.M., Homieda M.M.A., Ali H.M., Abbas Khider & Mohamed M.M.A., Ali H.M. Abbas Khider &Mohamed Siddeg. Chloroquine-Resistant Malaria: An evidence for its presence in Sudan 13th Sudanese Physicians Conf. Feb 1992 Khartoum.

10) Ali H.M., Homieda M.M.A.1990. The impact of flood disaster on health and nutritional status of the population, Khartoum, Sudan. Presented in: National Seminar on Disaster Prevention & Management in Sudan, 17-19 March 1990, organized by the University of Khartoum in collaboration with UNESCO, University of Khartoum, Khartoum, Sudan.

11) Ali H.M. 1989. National Drug Policy, Problems and Solutions 1989 Sudanese Islamic Medical Association Conference, Khartoum, Sudan.

12) Ali H.M. 1989 National Research Priorities on Drugs, Vaccines and Medicinal/Aromatic Plants. National Council for Research 1989 Conference, Khartoum, Sudan.

13) Mahmoud, B.M.; Ali H.M. & Homeida M.M.A. (1992). Chloroquine Interactions with common Sudanese Beverages: Reduced Bioavailability. 13th. Sudanese Physicians Conference, 4-6, Feb.1992, Khartoum, Sudan.

14) Hassan M. Ali (Dec 2007). Coordinator for: WHO Workshop: Teaching Rational Drug Use in Medical Schools. WHO & Federal MOH, Khartoum, Sudan.

15) Hassan M. Ali (Aug 2010). Consultant, Workshop in Pharmaceutical Human Resources Consultation: Towards Strategic Development Framework. Federal MOH (Sudan) In Coordination with WHO & FIP.

16) Hassan M. Ali (July 2011). International Regulations of Bioequivalence. Sudan First Bioequivalence Conference. NM&PB (MOH, Sudan) – WHO.

17) Hassan M. Ali (Feb 2012). Chairman: Pharmaceutical Services & Pharmacology Scientific Sessions. Health Challenges, Trends and Solutions. The First International Health Conference. Khartoum Friendship Hall, Khartoum College of Medical Sciences.

9

18) Hassan M. Ali (May 2012). Dangers of Counterfeit Drugs in Workshop: Pharmaceutical services In Sudan: Present Challenges. WHO-NM&PB (MOH, Sudan) & Al-Razi College for Medical Sciences.

19) Hassan M. Ali (June2012).Clinical pharmacokinetics in disease states, in RDF Seminar : Bioequivalence Studies, Present Challenges, RDF ( MOH, Khartoum State).

20) Hassan M. Ali ( 2013 ).Workshop : Veterinary Drug Residues in Food Derived From Animals; Commentator : (1) The Requirement of Establishing MRLs, ADI For Establishing of a Withdrawal Period & (2) Food Safety Concerns of Insecticides, Pesticides and Fertilizers. National Medicines & Poisons Board, Fed. Ministry of Health, Republic of Sudan, Khartoum, (May 26 – 27, 2013 ).

21) Hassan M. Ali, Seminar Coordinator ( September 17, 2014 ).Opportunities for establishing clinical research & health care standards & accessibility in Sudan. National Univ.-Sudan, Khartoum, Sudan. By: ANTAEA GROUP ( Athens, Greece ) in cooperation with FUTURE BEACON ( Amman, Jordan ).

ii) Regional Conferences 22) Ali H.M. & Beckett A.H. 1981. Identification of a new metabolite after incubation of N-

benzylaniline with rabbit liver microsomes. 17th. Egyptian Conference of Pharmaceutical Sciences, Cairo, Egypt.

23) Ali H.M., Hussein F.T &Abdulla W.A. 1981. Bioequivalence of three brands of Amoxicillin marketed in Egypt. 17th. Egyptian Conference of Pharmaceutical Sciences, Cairo, Egypt.

24) Ali H.M., Homeida M.M.A., Sulaiman S.M. and Bennett J.L. 1983. Effect of hepatosplenic schistosomiasis, Primary hepatocellular carcinoma & infective hepatitis on Ampicillin body level. IUPSPHAR 2nd. Conference, cairo, Egypt-Oct. 1983- Ali H.M- Chaired session 5: prostaglandins & Anti-inflammatory drugs.

25) Ali H.M., Homeida M.M.A., & El-Tahir K.E.D.H. 1984. The need for drug utilization studies. 2nd. Arab Drug Symposiumm; Rhiyad, Saudi Arabia, Nov, 1984.

26) Ali H.M., Homeida M.M.A., Abdeen M.A.R. & Rasheed A. Introducing the concept of essential drugs in universities curricula. 1st. Int. Congress of Pharmacy & the III-world- FIP; Cairo, Egypt. Feb.27-March 1, 1986.

27) Ali H.M. 1986. The concept of essential drugs proves its worth for African countries. 1st. Int. Congress of Pharmacy & the III-world- FIP; Cairo, Egypt. Feb.17-March 1, 1986.

28) El-Wakeel E.S., Homeida M.M.A., Ali H.M., Geeary T.C. & Jensen J.B. 1986. Clindamycin antimalarial activity in Sudanese patients. The Int. Con. Parasit. Disease; Cairo, Egypt. 1985.

29) Ali H.M. (1992). Drug Utilization: Methods & Significance. Nile Essential Drugs Project (WHO) in collaboration with the administration of Pharmacy, MOH, Sudan.

III Conference of the Union of African Societies of Pharmacology Workshop on Teaching of Pharmacology, Cairo (Egypt) 2-6 Dec. 1987. (28-31)

30) Ali H.M., Homeida A.E.G.M. & Younan, W.I. Oxytetracycline bioavailability in camels after I.V & I.M administration of 0.5 mg/Kg single doses.

31) Mahmoud B.M., Homeida M.M.A., Ali H.M., Farouk A., Geary T.G. & Jensen J.B. Interafrican transfer of chloroquinne/quinine-resistant plasmodium: Tanzania to Sudan.

32) Ali H.M., Bashir S.H., Homeida M.M.A., Suliman S.A. & El-Tahir E.T.M. Intestinal absorption in Sudanese duodenal ulcer & portal hypertension patients.

33) Ali H.M., Homeida M.M.A. Drug utilization concept and principle have an important place in Pharmacotheraputics today in universities faculties of pharmacy and medicine in developing countries (Workshop). Ali H.M.: Chairman:

i. Session 12, Gastrointestinal, 3 Dec. 1987. ii. Workshop Topic: Strategies and Assessment, 5 Dec. 1987.

Panel Member: iii) Workshop Topic: Curriculum Planning- Objective, 4Dec.19987. iv) Workshop Final Session: Summaries- 6Dec. 1987. Cairo, Egypt.

11

34) Younan W.I., Ali H.M. & Homeida A.G., (1992). Antibiotics & Sulfonamides in camels and Goats. Int. Conference on Camel research, Dubai, Feb. 1992.

35) Hassan M. Ali (Feb 2011). The Resistance Scourge: What can we do? Scientific Symposium, Hikma Pharmaceuticals, Dubai, UAE.

36) Hassan M. Ali (April 2011).Challenges in Bioequivalence. The Fourth Middle East Bioequivalence Conference. JAPM (Jordan) – FDA (MOH, Jordan) & USAID (USA).

37) Hassan M. Ali ( April 2014 ). 17th Arab Summit for Pharmaceutical Manufacturers & the 1st Exhibition PHINDEX-1, The Arab Union of the Manufacturers of Pharmaceuticals & Medical Appliances ( AUPAM ), April 9-11/2014 , Amman, Jordan.

38) Hassan M. Ali (2014 ). Member of the Organizing Committee, The First Conference for Medicines Regulatory Authorities in Sudan & Neighboring Countries , By: Sudan NM&PB – WHO, Khartoum, Sudan, ( Dec 6 – 8, 2014 ).

39) Hassan M. Ali . A Focus On Biorelevant Dissolution Tests & Bioequivalence Studies Workshop; The Vibrant Intersection Between Dissolution & Bioequivalence. By: The Arab Union Of The Manufacturers Of Pharmaceuticals & Medical Appliances ( AUPAM ) in collaboration with ACDIMA ( of the Pan Arab League ), P.O.Box; 925161 Amman 11190, Jordan; biocenter@acdima.com, ( 17th – 19th , February 2015 ).

40) Hassan M. Ali, Futeruristic Outlook of Arab Pharma Industry, In: 18th AUPAM Meeting, Amman, Jordan ( 5th – 7th May, 2015 ).

iii) International Conferences

41) Ali H.M. & Beckett A.H. 1979. Metabolic oxidation of a tertiary amine (cyproheptidine) to produce an N-glucuronide. 2nd. International symposium on the biological oxidation of Nitrogen. Chelsea College, University of London (UK).

42) Homeida M.M.A., Ali H.M., Bennett J.L. & Suliman S.M. investigation on the bioavailability of the Schistosomal drug: Oltipraz. American Society of Tropical Medicine and Hygiene, Cleveland, Ohio. USA. Nov.9, 1982.

43) Ali H.M. & Hassan I.E.Z. Ampicillin body levels in disease states: Viral hepatitis, primary hepatocellular carcinoma and hepatosplenic schistosomiasis. American society of Pharmac. Exp. Ther., Washington D.C., USA Ali.g. 1983.

44) Ali H.M., Homeida M.M.A., Bennett J.L. & Suliman S.M. Effect of dietary factors on Oltipraz blood levels in healthy subjects. American society of Pharmac. Exp. Ther., Washington D.C., USA. 1983.

45) Ali H.M., El Nour I.B. Sudanese phenotyping with S. diazine- FIP. Montreaux, Swizerland, Sept. 1983.

46) Ali, H.M. Sulaiman S.M., Homeida M.M.A.& Bennett J.L. effect of cysteine on Oltiparz FIP Montreaux Switzerland, Sept. 1983.

47) Homeida M.M.A., Ali, H.M., Bennett J.L. & Sulaiman S.M. Oltipraz and other antischistosomal agents overview. WHO, Geneva, Switzerland, Dec. 1983.

48) El-Tahir K.E.D.LI., Ali, H.M. Osman O.H. & Shakir L.S. The interactions between MAOIs and some centrally acting drugs. British Pharmacol. Soc., Leicester (UK) 6-8 July 1983.

49) Ali, H.M., Homeida M.M.A., Bennett J.L. & Sulaiman S.M. Dietary Influence on Oltipraz antischistosomal efficacy and pharmacokinetics in Sudan. IUPHAR, London, England, Ali.g. 1984.

50) Ali, H.M. Ampicillin interaction with chloroquine in human. Med. Chemother., Rhodes, Greece, Oct. 1984.

51) Ali, H.M., 1984. WHO- Working group: The interaction of the concept of essential drugs in universities curricula, Geneva, Switzerland; Dec. 10-04, 1984( Invited Participant).

52) Ali, H.M. 1986. Clinical pharmacology teaching based on the concept of essential drugs; country report, Sudan. Int. Working Group Meeting. Milano, Italy, May 26-30, 1986.(Invited Speaker; chaired some of the sessions).

53) Homeida M.M.A., Ali, H.M., Bennett J.L. & Sulaiman, S.M. Comparative study of

11

antischiostosomal activities of two Praziquantel brands. The 16th. S.E. Asian Seminar on Trop. Med., Seoul, Korea; Sept. 23-30, 1985.

54) Ali, H.M. Panel Member –Symp.: Primary hepatocellular carcinoma & dietary factors: Alfotoxins. The S.E. Asian Seminar on Trop. Med., Seoul, Korea, Sept. 23-30, 1985.(Invited).

55) Ali, H.M. Vice President, Working Group: Education & Information & the concept of essential drugs, Pharmaceutical problems in developing countries, Haikko, Finland, Ali.g. 26-31, 1986.(Invited).

56) Daneshmend T.K., Homeida M.M.A, Ali, H.M &Kaye c>m> Metronidazole kinetics in children with giardiasis following oral benzoylmetronidazole suspension. Br. Pharmacol. Soc., UK, Sept. 9-11, 1985.

57) Sulaiman S.M., Mackenzi C.D., Ali, H.M., Hmeida M.M.A. &Bennett J.L. Efficacy of a new Hoffmann La-Roche compounded (R0-15-5458/000) against S.Mansoni (Gezira stran, Sudan) in the Verve monkey (Cercopithecus aethiops). The IX Int. Cong. Of parasitic &Infectious Disease, Munich, W.Germany: July 20-26, 1986.

III world Conference of Clinical Pharmacology, Stockholm Sweden, July 27 Aug. 1 1986(52-54)

58) Ali, H.M. 1986. Problems in assessing rationality of drug utilization in less developed countries. Invited presentation (symp. Drug Utilization in relation to morbidity).

59) Bashir S.H., Ali, H.M. & Homeida M.M.A. 1986. Effect of ethnic origin on gastrointestinal absorption in healthy subjects.

60) Homeida M.M.A., Ali, H.M., Geary T.C. & Jensen J.B. Comparative study of antimalarial activity: clindamycin vs. chloroquine in Sudan.

61) Ali, H.M., Homeida M.M.A., Ford J., Truman C.A., Roberts C.J.C. & Badwan A.A. Paracetamol bioavailability and pharmacokinetics from an alcohol free solution, a suspension & an elixir. IV Clinical Pharmacology, Menheim, Germany 1 July 1989.

62) Homeida M.M.A., Ali, H.M. & Harror D.W.G. Propranolol bioavailability in patients with hepatosplenic schistosmiasis. Clinical Pharmacology 1 July 1989.

63) Ali, H.M. 1987 WHO Drug Utilization Research Group Meeting Discussion of new projects and the draft chapters of the revised drug utilization book. Oslo, Norway, Sept. 27-30, 1987. Invited.

64) Ali, H.M. 1987 delivered a talk on the closing ceremony as the official representative of the IUPHAR to 1st Congress of Toxicology in Developing Countries. Buenos Aires, Argentina, Nov. 16-22, 1987.

65) Ali, H.M. 1988. WHO Teaching Seminar on “Drug Epidemiology as an essential component of a Rational Drug Policy” Harare, Zimbabwe, Jan. 11-16, 1988.(Invited).

66) Ali, H.M. Lidia Nortarriani, Rana M. Azzam. The Suitability of Diazepam as a probe for CYP2C19 isoenzymme activity in Jordanains. The 2nd International Clinical Pharmacology Conference, Opportunities & Challenges. April 21-22/1999, The Faculty of Pharmacy, University of Jordan.

67) Ali,H.M., Rinad Bsoul, Mohammed Barakat, Kheder Mustafa, Haifa Al-Asali & Lama Bobali. Drug Prescribing Rationality in Outpatients Departments in Amman Hospitals. The 2nd International Clinical Pharmacy Conference, Opportunities & Challenges. April 21-22/1999. The Faculty of Pharmacy, University of Jordan.

68) Ali, H.M., Road to Universal Health Coverage for Sudan . International Conference, Min. of Welfare & Social Security ( Sudan ), National Health Insurance Fund ( Sudan ) in Collaboration with Federal MOH (Sudan ), Khartoum State HIC ( Sudan ), European Union Delegation & WHO. Khartoum, Sudan, 25-26 January 2014.

C. Postgraduate Degrees Programs Supervised

1. Determination of Acetylator Phenotype of a Sudanese Population using Sulphadiazine (Mrs. Ibtihag B. AlNour) Sudanese. M.Pharm.Sep.1982 H.M. Ali

12

2. Toxic interactions between Monoamine Oxidase Inhibitors & some centrally acting drugs. (Mrs. S. Shakir) Sudanese. M.Pharm. April. 1983 H.M. Ali &K.E.D.H. Al Tahir

3. Effect of Ethnic origin & some liver diseases (Hepatosplenic Schistosomiasis & primary Hepatocellular carcinoma) on Ampicillin disposition and pharmacokinetics). (Mr. I. Al Zaine Hassan) Sudanese.M.Pharm. Nov. 1985 H.M. Ali & M.H.A. Homeida

4. Evaluation of bioavailability of some beta lactam antibiotics marketed in Sudan. Nov, 1985. (Mr. Babikir M. Mahmoud) Sudanese. M.Pharm. Nov. 1985 H.M. Ali

5. Investigations on the influence (s) of ethnic origin, portal hypertension & duodenal ulcer on intestinal absorption in Africans. (Mrs. Saadia B. Hassan) Sudanese. M.Pharm. Dec. 1986 M.M.A Homeida & H.M. Ali

6. Oxytetracyclme and Ampicillin disposition pharmacokinetics and tissue (s) residues (Milk, liver… etc.) in Camel and Goats following intravenous & and intramuscular dosing.(Miss Wasfa I. Younan) Sudanese. MSc May. 1988 H.M. Ali , A.G.M Homeida

7. Investigations on chloroquine disposition , pharmacokinetics and bioavailability in health and disease state. Efficacy and parasite resistance. (Mr. Babikir M.Mahmoud) Sudanese. Ph.D. April 1990 H.M. Ali M.M.A. Homeida.

8. Pharmacological and toxicological investigations on a Sudanese plant (Capparis Tomntosa) in Goats and Rodents. (Miss. Siham A.E.R. Ahmed) Sudanese. M.Pharm. Jan. 1990 H.M. Ali &S.E.I. Adam.

9. Pharmacotheraputic and pharmacokinetics investigations on the Anti-Schistosomal drugs. Praziquantel in health and disease state. (Mr. M. Al Mahdi) Sudanese. M. Pharm. Jan. 1989 H.M. Ali M.M.A. Homeida , T.E. Sadig & J.L. Bennett

10. Studies on Ampicillin interactions with whole Sorghum meal and Sorghum tannins following oral dosing to healthy Sudanese. (Mr Waeil O. Babikir) Sudanese. M. Pharm. March 1992 H.M. Ali & M.M.A Homeida

11. The magnitude of Ampicillin and Tetracycline interactions with Sudanese food in an urban community in Khartoum region. (Miss N. Al Nigomi & Miss E.H. Osman) Sudanese. B.Sc. in Family Sciences Jan 1991 H.M. Ali

12. General investigations on Ampicillin disposition and metabolism. (Miss Nadia H. Banaga) Sudanese. B.Sc. in Family Sciences Jan 1992 H.M. Ali & E.F. Idris

13. Pharmacokinetic investigations on some antihistaminic drugs. (Mr. Adnan Al Adhal) Yemeni. M.Pharm. April 1998, H.M.Ali & I.B.A L Taeib

14. Comparative bioavailability studies on antibiotics marketed in Yemen. ( Mr. Ahmed Galib) Yemeni. M.Pharm. Nov.1998 H.M. Ali ,Al Fatih Idris & N.S. Ghanem

15. An investigation on the suitability of Diazepam as a probe for CYP2C19 in Jordanians. (Miss Rana M. Azzam) Jordanian. M.Phil 1999 H.M. Ali ,L. Notarriani & S. Moss.

16. MSc Project: Antibacterial Effect of Some Sudanese Bees Honey. Awatif Osama M. Mahmoud. UMST, Khartoum (2006-2008) .

17. MSc Project: The Awareness of Prescribers and Dispensers towards the Concept of Rational Drug Use in Khartoum City. Ziryap Imad Taha. UMST , Khartoum (2007-2009).

18. MSc Project: Audit of the Acute Bronchial Asthma Management at the Emergency Department in Wad Madani Pediatrics Teaching Hospital. University of Gezira (2007-2009).

19. MSc Project: Therapeutic management of Ulcer: The Rationale of Current Drug Combinations Therapy. Mohammed Al Tohami, UMST, Khartoum ( 2007- 2009 ).

20. MSc Project: Current Situation of Unlicensed Herbal Products Circulating in Khartoum State: Contents Analysis & Implications . Tarig Osman Saeed. UMST, Khartoum ( 2007-2009).

21. MSc Project: Paracetamol Pharmacokinetics from: Paracetamol 500 mg – Metclopramide 5 mg tablets: Paramax (Sanofi – Synthelabo, Ireland) vs Paramide 505 (Amipharma, Sudan) In-Vivo & In Vitro Study, Doaa A. Al-Habobi, UMST, Khartoum (2007-2009).

22. MSc Project: Comparative pharmacokinetic profile of Paracetamol 500 mg tablets from: Amidol, Panadol and Panadol Actifast In -Vitro, Ameer Saad Ahmed Ibrahim, UMST, Khartoum (2010-2012).

13

23. MSc Project: Prescribing Rationality in Khartoum State Teaching Hospitals: Situation Analysis. Mohamed Haider Hassan Ibrahim. UMST (2010-2012).

24. MSc Project: Statins Play On Memory: Awareness of Prescribers In Khartoum Public and Private Hospitals. Tayseer Salih. UMST, Khartoum (2010-2012).

25. MSc Project: Levodopa-Carbidopa Multilayer tablets: Formulation and In-Vitro Evaluation . Ashraf Aziz, UMST, Khartoum (2010-2012).

26. MSc Project: Comparative Pharmacokinetic profile of Doxacycline 100 mg capsules fromAmidoxine and Vibramycin: In-Vitro; Mohamed Abdallah Mohamed, UMST, Khartoum (2010-2012).

27. MSc Project: The Hazards of Hidden Heavy Metals in Face, make-ups in Sudan; Sabah Elseid Abozeid, UMST, Khartoum (2010-2012).

28. MSc Project: Comparative pharmacokinetic profile of Diclofenac 75 mg from Diclofenac SR-tablets and Divido DR capsules in healthy human volunteers ; Mohamed Jalal Eldin, UMST, Khartoum (2010-2012).

29. MSc Project: Biowaiver Monograph for Propranolol Immediate Release Oral Solid Dosage Form. Sohad M. F. Sabry, UMST, Khartoum, Sudan (2010-2012).

30. MSc Project: Biowaiver Monograph for Prednisolone 5 mg Immediate Release Oral Solid Dosage Form. Selma I. Elamin , UMST, Khartoum, Sudan (2010-2012).

31. MSc Project: Prescribing Practices of Antibiotics in Khartoum State Public & Private Hospitals: Generic vs Brand Prescribing. Sarrah Abbas Aboshama. UMST, Khartoum (2011–2013).

32. MSc Project: Adherence of Medical Practitioners to the National Malaria Protocol in Primary

Health Centers in Khartoum Locality, Sudan. Al-Husein M. Chayd, UMST, Khartoum, Sudan. (2011- 2013).

33. MSc Project: The Awareness of Prodrugs Among Medical Practitioners in Khartoum Province. Hilali A. Hilali, UMST, Khartoum, Sudan. (2011- 2013).

34. MSc Project: Comparative Study of the Dissolution Profile of Two Conventional Paracetamol Tablet Dosage Forms vs A Fast Release Formulation. Maha Y. Suliman , UMST, Khartoum, Sudan (2011-2013).

35. B. Pharm Project: Induced Antibiotic Resistance in Humans due to the Misuse of Veterinary Antibiotics in Poultry in Khartoum State. Mekaiel A. Mekaiel, National University - Sudan, Khartoum , Sudan (April 2013–February 2014 ).

36. MSc Project: Drug Utilization Study of Psychotropic Drugs Prescribed in Outpatient Departments in Khartoum Mental Hospitals. Hana F. Mohamed, UMST, Khartoum, Sudan. (2013- 2014).

37. MSc. Project: Assessment of Rational Use of Asthma Medications among Asthmatic Patients in Bahri and Alshaab Teaching Hospitals ; Hala Tajelsir Ahmed; UMST, Khartoum, Sudan (2014).

D. Examiner for the Award of Postgraduate Degrees ( MSc & PhD) &

Assessor For The Promotion Of Academics To The Positions Of Assoc. Prof. & Prof. :

I have been appointed by the following Higher Education & Research Institutions as an

Examiner for the Award of the M.Sc. & PhD degrees and as an Assessor for the Promotion to the

Positions of Assoc. Prof. & Professor, of their Academic Staff and Research workers (2006 –

present):

Faculty of Pharmacy, Univ. of Khartoum, Khartoum, Sudan.

Faculties of pharmacy & Medicine, Univ. of Medical Sciences & Technology, Khartoum,

Sudan.

Faculty of Pharmacy, The National Ribat Univ. , Khartoum, Sudan.

Faculty of Pharmacy, Ahfad Univ. For Women, Omdurman, Sudan.

Faculty of Medicine, Univ. of Al Neel, Omdurman, Sudan.

14

Faculty of Pharmacy, Univ. of Al Gezira, Wad Madani, Sudan.

Faculty of Pharmacy, Univ. of Bengazi, Bengazi, Lebia.

Faculty of Pharmacy, Univ. of Sanaa , Sanaa, Yemen.

Faculty of Pharmacy, Univ. of Petra, Amman, Jordan.

Faculty of Medicine, Qassim University, Kingdom of Saudi Arabia.

Animal Resources Research Corporation, Ministry of Livestock, Fisheries & Rangelands,

Republic of the Sudan, Khartoum, Sudan.

Jordanian Ministry of Higher Education & Research.

Faculty of Pharmacy, Omdurman Islamic University.